Politics | 12/29/2008 10:40 am
Botox Mascara? Not Quite! The Makers of Botox Launch First FDA-OK Drug for Fuller, Longer Lashes

The drug company behind the anti-wrinkle drug Botox has developed a new drug to give you sexier-looking lashes to go with your youthful-looking post-toxin-injected face
Allergan, which is behind Botox, has created a new prescription medication that promises to promote eyelash growth and fullness. Latisse will be the first FDA-approved eyelash drug that, when applied once daily with a disposable applicator to the eyelid, could improve the length, thickness and darkness of hairs, according to the product information provided on the brand’s website.
The drug doesn’t work in the blink of an eye, though. Prolonged use guarantees thick, luscious lashes. And potential side effects include dry eyes, darkening of the eyelid skin and iris, abnormal hair growth in untreated areas, headaches and more. The ingredient that is responsible for the eyelash growth is said to be prostaglandin, which is naturally present in hair and is believed to help in the regrowth of hair follicles. Prostaglandin can also be found in some glaucoma medications, and past clinical and observation studies documented eyelash growth in patients taking meds to treat their eye disease.
Latisse will hit pharmacies early next year and a 30-day supply is expected to cost $120 — about ten times more than the price of your drugstore mascara.























13 Reader Comments (so far…) Sign In or Register to comment
The health fairy hasn’t been kind to my cousin. 50 years old and wheelchair bound, oxygen-connected and cortisone-plumped, I wouldn’t consider her alluring. Although at a recent visit, I couldn’t help noticing my cousin’s eyelashes. They looked "spidery;" super long and curly, like the fake lashes worn by drag queens. "Awesome lashes," I told her. "My doctor has me on eye drops for glaucoma," she explained. "Now my lashes are growing out of control; they squish into my eyeglasses." I asked if she’d heard that a side effect of glaucoma drops is lash growth. "My ophthalmologist never mentioned that, but knowing it now is a big relief," she said. I also told her how a few beauty companies had illegally used the drug in OTC lash growth products, until the FDA got wind of it. Tempted to ask if I could try her eye drops, instead I offered to trim her lashes for her; she refused to let me.
Although this seemingly miraculous lash growth is no longer attainable over-the- counter, Allergan (maker of Lumigan, the eye drops for glaucoma) just introduced Latisse, the first and only FDA approved prescription drug for growing longer, fuller lashes. In a clinical trial, lashes typically grew 25 percent longer, 106 percent thicker and 18 percent darker.
Parting ways with your lash curler and never fussing with mascara again is a convenient concept, but unless you already indulge in professional lash extensions or you wear mink eyelashes like Madonna does, the $120 price tag for a monthly dose of Latisse might seem extravagant. If so, plump your peepers the old fashioned way: In a recent review in Consumer Reports Shop Smart Magazine, Lancome Paris Definicils, $24, got the highest marks. The runner up: Max Factor Lash Perfection Volume Couture, $7. Honorable mentions include Maybelline Defin-A-Lash, $8 and L’Oreal Telescopic Clean Definition, $9.Wendy Korn Heppt budgetstyleonashoestring.blogspot.com/ wendykorn@yahoo.com